Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase Ib |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase Ib randomized double-blind clinical trial to examine whether polytopic administration of VRC rAd5 Gag/Pol, Env A/B/C vaccine enhances HIV-specific cellular immune responses in humans
Description
HVTN 085 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of combinations of rAd5 (VRCHIVADV014-00-VP, VRCHIVADV038-00-VP, VRCHIVADV052-00-VP, VRCHIVADV053-00-VP, and VRCHIVADV054-00-VP).
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.